Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,077 public trials 1,842 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

NCT04152499

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
Locations
  • Los Angeles Hematology Oncology Medical Group Glendale, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • START MidWest Grand Rapids, Michigan, United States
View all 109 locations
View Trial Details
Active, Not Recruiting

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

NCT04716946

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations
  • Baptist Alliance - McI Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT06162572

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Loma Linda University Loma Linda, California, United States
  • Henry Ford Health Detroit, Michigan, United States
  • Comprehensive Cancer Center of Nevada Las Vegas, Nevada, United States
  • Gabrail Cancer Center Canton, Ohio, United States
View all 63 locations
View Trial Details
Active, Not Recruiting

A Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT06448312

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hebei University Affiliated Hospital Baoding, China
  • Beijing Chest Hospital. Capital Medical University Beijing, China
  • Beijing Institute for Cancer Research Beijing, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
View all 64 locations
View Trial Details
Active, Not Recruiting

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

NCT06295731

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +19 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Los Angeles Cancer Network (LACN) Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Medical Oncology Associates of San Diego San Diego, California, United States
View all 87 locations
View Trial Details

Related conditions